SYNTHESIS, ANTIMICROBIAL, ANTICANCER EVALUATION AND QSAR STUDIES OF THIAZOLIDIN-4-ONE DERIVATIVES. 2016

Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani

In this study, a novel series of 4-thiazolidinone derivatives (1-17) was synthesized and evaluated for its in vitro antimicrobial and anticancer potentials. N-(2-(5-(4-nitrobenzylidene)-2-(4-chlorophenyl)-4-oxothia- zolidin-3-ylamino)-2-oxoethyl) benzamide (7, pMICam = 1.86 µM/mL) was found to be the most active antimi- crobial agent. The anticancer study results demonstrated that N-(2-(5-(4-hydroxybenzylidene)-2-(4- methoxyphenyl)-4-oxothiazolidin-3-ylamino)-2-oxoethyl) benzamide (10, IC₅₀ = 18.59 µM) was the most active anticancer agent. QSAR studies indicated the importance of topological parameter, Kier's α third order shape index (κα₃) as well as electronic parameters, cosmic total energy (cos E) and energy of highest occupied molecular orbital (HOMO) in describing the antimicrobial activity of synthesized compounds.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D053778 Thiazolidines Reduced (protonated) form of THIAZOLES. They can be oxidized to THIAZOLIDINEDIONES. Thiazolidine
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
August 2013, Current topics in medicinal chemistry,
Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
January 2015, Current topics in medicinal chemistry,
Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
August 2011, Organic and medicinal chemistry letters,
Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
September 2021, Bioorganic chemistry,
Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
May 2009, European journal of medicinal chemistry,
Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
April 2011, European journal of medicinal chemistry,
Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
February 2014, Drug research,
Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
December 2010, Bioorganic & medicinal chemistry letters,
Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
January 1985, Il Farmaco; edizione scientifica,
Aakash Deep, and Pradeep Kumar, and Balasubramanian Narasimhan, and Siong Meng Lim, and Kalavathy Ramasamy, and Rakesh Kumar Mishra, and Vasudevan Mani
May 2008, Medicinal chemistry (Shariqah (United Arab Emirates)),
Copied contents to your clipboard!